Xu Xianpeng, Guo Tao, Liu Zifeng, Chen Peng, Zhang Ying, Ji Qingjie, Xie Hui
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China.
Quzhou Hospital of Traditional Chinese Medicine, Quzhou, People's Republic of China.
Patient Prefer Adherence. 2022 Oct 20;16:2867-2876. doi: 10.2147/PPA.S388356. eCollection 2022.
To comprehensively summarize the evidence on the preferences, expectations, and values of hypertension management and treatment in hypertensive patients.
From inception through January 2022, PubMed, Embase, Web of Science, EBSCO, and China National Knowledge Infrastructure were searched for studies with hypertension value, preference, or expectation. A qualitative retrospective analysis was performed.
A total of 24 studies involving 8701 participants were included. Although studies on the preferences of hypertensive patients are difficult to standardize, considerable convergence has occurred: 1) Patients preferred treatment regimens with lower incidence of comorbidities, faster response, lower cost, more frequent blood pressure monitoring, fewer side effects, and more convenient medication. 2) Patients have a crucial role in the treatment, and their physicians are expected to develop a shared patient-centered decision-making model.
The results of this systematic review demonstrated that side effects, cost, and convenience are important factors for patients when selecting a treatment regimen for hypertension. Patients often obtain hypertension information from their physicians and prefer shared patient-centered decision-making.
全面总结高血压患者对高血压管理和治疗的偏好、期望及价值观方面的证据。
从数据库建立至2022年1月，检索了PubMed、Embase、Web of Science、EBSCO和中国知网中有关高血压价值观、偏好或期望的研究，并进行了定性回顾分析。
共纳入24项研究，涉及8701名参与者。尽管关于高血压患者偏好的研究难以标准化，但已出现相当程度的趋同：1）患者更喜欢合并症发生率较低、反应更快、成本更低、血压监测更频繁、副作用更少且用药更方便的治疗方案。2）患者在治疗中起关键作用，期望其医生建立以患者为中心的共同决策模式。
该系统评价结果表明，副作用、成本和便利性是患者选择高血压治疗方案时的重要因素。患者常从医生处获取高血压信息，且更喜欢以患者为中心的共同决策。
